Skip to main content

Advertisement

Log in

Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study

  • Original Article
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

Objective

Bariatric surgery (BS) improves glycemic control in type 2 diabetes; however, some patients show insufficient improvement. Understanding the pathophysiology of type 2 diabetes in obese patients can facilitate appropriate treatment for type 2 diabetes after BS. The homeostatic model assessment (HOMA) 2 enables the calculation of the values from C-peptide data and evaluation of insulin users. We aimed to evaluate the pathophysiology of type 2 diabetes using pre- and postoperative parameters and HOMA2 in obese patients who underwent BS.

Methods

We retrospectively reviewed data from 45 obese patients with type 2 diabetes who underwent BS. They were followed-up for 12 months. The relationship between the HOMA2 score and complete remission (CR) of type 2 diabetes after BS was analyzed. Patients with and without CR were assigned to the CR and non-CR groups, respectively. Multiple regression analysis was used to identify factors associated with improvement in type 2 diabetes after BS.

Results

BS significantly improved body weight and glucose metabolism. The preoperative glycosylated hemoglobin A1c level and insulin secretion (HOMA2-%B) significantly differed between the CR and non-CR groups. Postoperative weight reduction and improved insulin sensitivity correlated significantly with CR; multiple regression showed that the preoperative HOMA 2-%B independently predicted CR of type 2 diabetes after BS.

Conclusion

Preoperative insulin secretion, improvement in insulin sensitivity, and weight reduction after BS are related to CR of type 2 diabetes after BS. The results better reveal the pathophysiology of and treatment for type 2 diabetes in obese patients who undergo BS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.

    Article  CAS  Google Scholar 

  2. Khorgami Z, Shoar S, Saber AA, Howard CA, Danaei G, Sclabas GM. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg. 2019;29:964–74.

    Article  Google Scholar 

  3. Lee MH, Lee WJ, Chong K, Chen JC, Ser KH, Lee YC, et al. Predictors of long-term diabetes remission after metabolic surgery. J Gastrointest Surg. 2015;19:1015–21.

    Article  Google Scholar 

  4. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.

    Article  CAS  Google Scholar 

  5. Li YX, Fang DH, Liu TX. Laparoscopic sleeve gastrectomy combined with single-anastomosis duodenal-jejunal bypass in the treatment of type 2 diabetes mellitus of patients with body mass index higher than 27.5 kg/m2 but lower than 32.5 kg/m2. Medicine (Baltimore). 2018;97:e11537.

    Article  Google Scholar 

  6. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Tumer RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.

    Article  CAS  Google Scholar 

  7. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21:2191–2.

    Article  CAS  Google Scholar 

  8. Song YS, Hwang YC, Ahn HY, Park CY. Comparison of the usefulness of the updated Homeostasis model Assessment (HOMA2) with the original HOMA1 in the prediction of type 2 diabetes mellitus in Koreans. Diabetes Metab J. 2016;40:318–25.

    Article  Google Scholar 

  9. Auguet T, Terra X, Hernández M, Sabench F, Porras JA, Orellana-Gavaldà JM, et al. Clinical and adipocytokine changes after bariatric surgery in morbidly obese women. Obesity. 2014;22:188–94.

    Article  CAS  Google Scholar 

  10. Mathieu C, Del Prato S, Botros FT, Thieu VT, Pavo I, Jia N, et al. Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme. Diabetes Obes Metab. 2018;20:2023–8.

    Article  CAS  Google Scholar 

  11. Saiki A, Yamaguchi T, Tanaka S, Sasaki A, Naitoh T, Seto Y, et al. Background characteristics and postoperative outcomes of insufficient weight loss after laparoscopic sleeve gastrectomy in Japanese patients. Ann Gastroenterol Surg. 2019;3:638–47.

    Article  Google Scholar 

  12. Fellici AC, Lambert G, Lima MM, Pareja JC, Rodovalho S, Chaim EA, et al. Surgical treatment of type 2 diabetes in subjects with mild obesity: mechanisms underlying metabolic improvements. Obes Surg. 2015;25:36–44.

    Article  CAS  Google Scholar 

  13. Benaiges D, Flores Le-Reox JA, Pedro-Botet J, Chillarón JJ, Renard M, Parri A, et al. Sleeve gastrectomy and Roux-en-Y gastric bypass are equally effective in correcting insulin resistance. Int J Surg. 2013;11:309–13.

    Article  Google Scholar 

  14. Zhu Y, Sun Z, Du Y, Xu G, Gong K, Zhu B, et al. Evaluation of insulin resistance improvement after laparoscopic sleeve gastrectomy or gastric bypass surgery with HOMA-IR. Biosci Trends. 2017;11:675–81.

    Article  CAS  Google Scholar 

  15. Liu T, Zhong MW, Liu Y, Sun D, Wei M, Huang X, et al. Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function. World J Gastroenterol. 2017;23:3468–79.

    Article  Google Scholar 

  16. Yan YX, Wang GF, Xu N, Wang FL. Correlation between postoperative weight loss and diabetes mellitus remission: a meta-analysis. Obes surg. 2014;24:1862–9.

    Article  Google Scholar 

  17. Park JY, Kim YJ. Prediction of diabetes remission in morbidly obese patients after Roux-en-Y gastric bypass. Obes Surg. 2016;26:749–56.

    Article  Google Scholar 

  18. Villarreal-Calderón JR, Cuéllar RX, Ramos-González MR, Rubio-Infante N, Castillo EC, Elizondo-Montemayor L, et al. Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxid Med Cell Longev. 2019;2019:3940739.

    Article  Google Scholar 

  19. Goktas Z, Moustaid-Moussa N, Shen CL, Boylan M, Mo H, Wang S. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:69.

    Article  Google Scholar 

  20. Pèrez-Pevida B, Escalada J, Miras AD, Frühbeck G. Mechanisms underlying type 2 diabetes remission after metabolic surgery. Front Endocrinol (Lausanne). 2019;10:641.

    Article  Google Scholar 

  21. Saiki A, Oyama T, Endo K, Ebisuno M, Ohira M, Koide N, et al. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract. 2007;76:93–101.

    Article  CAS  Google Scholar 

  22. Ohira M, Yamaguchi T, Saiki A, Nakamura S, Tanaka S, Oka R, et al. Laparoscopic sleeve gastrectomy significantly increases serum lipoprotein lipase level in patients with obesity. Obes Facts. 2019;12:357–68.

    Article  CAS  Google Scholar 

  23. Samaras K, Viardot A, Botelho NK, Jenkins A, Lord RV. Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery. Diabetologia. 2013;56:2564–72.

    Article  CAS  Google Scholar 

  24. Zagorski SM, Papa NN, Chung MH. The effect of weight loss after gastric bypass on C-reactive protein levels. Surg Obes Relat Dis. 2005;1:81–5.

    Article  Google Scholar 

  25. Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 2009;17:1671–7.

    Article  CAS  Google Scholar 

  26. Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease. J Exp Med. 2018;215:383–96.

    Article  CAS  Google Scholar 

  27. Genske F, Kühn JP, Pietzner M, Homuth G, Rathmann W, Grabe HJ, et al. Abdominal fat deposits determined by magnetic resonance imaging in relation to leptin and vaspin levels as well as insulin resistance in the general adult population. Int J Obes. 2018;42:183–9.

    Article  CAS  Google Scholar 

  28. Thamer C, Machann J, Staiger H, Müssig K, Schwenzer N, Ludescher B, et al. Interscapular fat is strongly associated with insulin resistance. J Clin Endocrinol Metab. 2010;95:4736–42.

    Article  CAS  Google Scholar 

  29. Saito T, Murata M, Otani T, Tamemoto H, Kawakami M, Ishikawa SE. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Endocr J. 2012;59:39–45.

    Article  CAS  Google Scholar 

  30. Lee WJ, Chong K, Ser KH, Chen JC, Lee YC, Chen SC, et al. C-peptide predicts the remission of type 2 diabetes after bariatric surgery. Obes Surg. 2012;22(2):293–8.

    Article  Google Scholar 

  31. Dixon JB, Chuang LM, Chong K, Chen SC, Lambert GW, Straznicky NE, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013;36:20–6.

    Article  CAS  Google Scholar 

  32. Wang GF, Yan YX, Xu N, Yin D, Hui Y, Zhang JP, et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg. 2015;25:199–208.

    Article  Google Scholar 

  33. Chong K, Ikramuddin S, Lee WJ, Billington CJ, Bantle JP, Wang Q, et al. National differences in remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery-subgroup analysis of 2 year results of the diabetes surgery study comparing Taiwanese with Americans with mild obesity (BMI 30–35 kg/m2). Obes Surg. 2017;27:1189–95.

    Article  Google Scholar 

  34. Yan H, Tang L, Chen T, Kral JG, Jiang L, Li Y, et al. Defining and predicting complete remission of type 2 diabetes: a short-term efficacy study of open gastric bypass. Obes Facts. 2013;6:176–84.

    Article  CAS  Google Scholar 

  35. Wentworth JM, Playfair J, Laurie C, Brown WA, Burton P, Shaw JE, et al. Gastric band surgery leads to improve insulin secretion in overweight people with type 2 diabetes. Obes Surg. 2015;25:2400–7.

    Article  Google Scholar 

  36. Dutia R, Brakoniecki K, Bunker P, Paultre F, Homel P, Carpentier AC, et al. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes. 2014;63:1214–23.

    Article  CAS  Google Scholar 

  37. Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11:489–506.

    Article  Google Scholar 

  38. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95.

    Article  Google Scholar 

Download references

Acknowledgements

The authors are grateful to Dr. Daiji Nagayama (Nagayama Clinic, Oyama-city, Tochigi, Japan) for his assistance with statistical analysis and to Sayaka Tsuji (Center for Diabetes, Endocrinology and Metabolism, Toho University Sakura Medical Center, Sakura-City, Chiba, Japan), a coordinator, for her assistance with patient care. The authors are also grateful to the radiologists who measured the fat mass in this study.

Funding

This study did not receive any funding.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. MO contributed to the research concept and design, collection and/or assembly of data, data analysis, and writing of the article. YW, TY, AS, SN, ST, NS, TN, and TO contributed to data collection and/or collation. IT contributed to the interpretation of the results of data analysis and to the critical revision of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Masahiro Ohira.

Ethics declarations

Conflicts of interest

The authors declare that they have no competing interests.

Research involving human participants and/or animals

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional) and/or with the Helsinki Declaration of 1964 and later versions. The protocol of the study was approved by the Ethics Committee of Toho University Sakura Medical Center (approval date; 28 November 2018, approval No.; S18061).

Informed consent

Although this was a retrospective study, patients were individually explained the issues relating to the use and release of the study data before the operation. Written consent was obtained in each case.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ohira, M., Watanabe, Y., Yamaguchi, T. et al. Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study. Diabetol Int 12, 379–388 (2021). https://doi.org/10.1007/s13340-021-00493-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-021-00493-7

Keywords

Navigation